Quality Control and Evaluation of Herbal Drugs 2019
DOI: 10.1016/b978-0-12-813374-3.00013-2
|View full text |Cite
|
Sign up to set email alerts
|

Bioassay-Guided Isolation and Evaluation of Herbal Drugs

Pulok K. Mukherjee
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 136 publications
0
8
0
Order By: Relevance
“…Cytotoxicity is the primary characteristic of compounds and substances in terms of their qualification as therapeutic agents and is the toxicity that a certain factor causes in live cells [ 76 ]. High cytotoxicity against rapidly dividing cancer cells in vitro is the basis for further research on their bioactivity (e.g., necrosis, autophagy, or apoptosis induction), low cytotoxicity on the other hand is desired in the development of drugs that are not intended to induce death in cells.…”
Section: Biological Activitymentioning
confidence: 99%
“…Cytotoxicity is the primary characteristic of compounds and substances in terms of their qualification as therapeutic agents and is the toxicity that a certain factor causes in live cells [ 76 ]. High cytotoxicity against rapidly dividing cancer cells in vitro is the basis for further research on their bioactivity (e.g., necrosis, autophagy, or apoptosis induction), low cytotoxicity on the other hand is desired in the development of drugs that are not intended to induce death in cells.…”
Section: Biological Activitymentioning
confidence: 99%
“…Cytotoxicity can be defined as the toxicity induced by chemotherapeutic drugs in live cells [157]. The viability of 3D models can be assessed after incubation with the metallodrugs through several methods, such as the alamar blue assay, MTT (3-(4,5-dimethyl-2thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay, CellTiter-Glo ® 3D Viability Assay, or acid phosphatase (APH) assay.…”
Section: Cytotoxicity Assaysmentioning
confidence: 99%
“…Although this approach is cost-effective, it generates a lot of incomplete information and necessitates a lot of genetic analysis [170]. According to Mukherjee [171], genotyping-by-sequencing's key strengths are its Despite NGS's advantages, it has several limitations. The requirement for PCR amplification before sequencing is a fundamental limitation of all 2G NGS approaches [166].…”
Section: Genotyping-by-sequencing (Gbs)mentioning
confidence: 99%